Trials / Completed
CompletedNCT03951714
Effect of the Use of an add-on Device Connected to a Smartphone App on Difficult-to-treat Asthmatic Patient's Adherence
12-wks Randomised Controlled Trial to Explore the Effect of a Smartphone App. Connected to an Add-on Device System Fitted on pMDI Inhaler on Adherence to Medications Intake and Clinical Outcomes in Difficult-to-treat Asthmatic Patients
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 160 (actual)
- Sponsor
- Chiesi Farmaceutici S.p.A. · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this Study is to assess the effect of a smartphone application connected to an add-on device system fitted on Pressured Metered Dose Inhaler (PMDI) on adherence to take medications as prescribed and clinical outcomes in difficult-to-treat asthmatic patients.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Marketed experience application on adherence | To evaluate the effect of electronic capture of medication intake through a smartphone app on treatment's adherence |
Timeline
- Start date
- 2019-08-12
- Primary completion
- 2020-07-06
- Completion
- 2020-07-06
- First posted
- 2019-05-15
- Last updated
- 2021-07-01
Locations
1 site across 1 country: United Kingdom
Source: ClinicalTrials.gov record NCT03951714. Inclusion in this directory is not an endorsement.